FDA panel votes against wider use of Amgen drug (Reuters)

[unable to retrieve full-text content]Reuters - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

Source: http://us.rd.yahoo.com/dailynews/rss/health/*http%3A//news.yahoo.com/s/nm/20120208/hl_nm/us_fda_amgen_xgeva

muammar gaddafi lord monckton lord monckton andy kaufman october 21 2011 ohio ohio